it was patented in 1980 and approved for medical use in 1987 it was developed by eli lilly brand names include tazac and axid nizatidine is used to treat duodenal ulcers gastric ulcers and gastroesophageal reflux disease gerd gord and to prevent stress ulcers side effects are uncommon usually minor and include diarrhea constipation fatigue drowsiness headache and muscle aches nizatidine was developed by eli lilly and was first marketed in 1987 it is considered to be equipotent with ranitidine and differs by the substitution of a thiazole ring in place of the furan ring in ranitidine in september 2000 eli lilly announced they would sell the sales and marketing rights for axid to reliant pharmaceuticals subsequently reliant developed the oral solution of axid marketing this in 2004 after gaining approval from the u s food and drug administration fda however a year later they sold rights of the axid oral solution including the issued patent protecting the product to braintree laboratories nizatidine proved to be the last new histamine h receptor antagonist introduced prior to the advent of proton pump inhibitors